• KemPharm Appoints Tamara A. Seymour to Board of Directors firstwordpharma
    August 19, 2021
    KemPharm, Inc. (NASDAQ: KMPH), a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs, announced today the appointment of Tamara A. Seymour to serve on its Board of Directors and as Chair of the Audit Committee
PharmaSources Customer Service